Related Experiment Video
Updated: Aug 9, 2026
09:48
Production of Transgenic Xenopus laevis by Restriction Enzyme Mediated Integration and Nuclear Transplantation
Published on: August 21, 2010
Protamine polymorphism in Xenopus laevis laevis
The Journal of Experimental Zoology
|June 1, 1987
Summary
Protamine gene expression in Xenopus laevis laevis frogs shows polymorphism, with allelic variants SP2a and SP2b. This genetic variation did not impact sperm development or function in the studied individuals.
Area of Science:
- Reproductive biology
- Molecular genetics
- Amphibian research
Background:
- Protamines are essential sperm nuclear proteins involved in DNA packaging.
- Understanding protamine gene expression is crucial for assessing reproductive fitness.
- Individual variation in protamine expression within a species is not well-documented.
Purpose of the Study:
- To investigate protamine gene expression polymorphism in individual Xenopus laevis laevis frogs.
- To determine if observed protamine variants affect sperm development or function.
Main Methods:
- Polyacrylamide gel electrophoresis (PAGE) was used to analyze protamines from individual frogs.
- Partial V8 protease digests were employed to compare protamine peptide fragments.
- Light and electron microscopy were utilized to assess sperm morphology and development.
Main Results:
- Two electrophoretic protamine variants, SP2a and SP2b, were identified, suggesting allelic expression.
- A significant portion of the frog population (11 out of 33) expressed both SP2a and SP2b variants.
- No discernible differences in sperm development or structure were observed between frogs with different protamine expression profiles.
Conclusions:
- Protamine polymorphism exists within Xenopus laevis laevis populations.
- This genetic variation in protamines does not appear to compromise sperm development or function.
- Further research may elucidate the evolutionary implications of protamine polymorphism.
Related Concept Videos
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...